Innovex (INVX) CFO receives 18,975-share stock award grant

Rhea-AI Filing Summary

Reed Kendal reported acquisition or exercise transactions in this Form 4 filing.

Innovex International, Inc. reported that Chief Financial Officer Reed Kendal received a grant of 18,975 shares of common stock on February 27, 2026 as a stock award with no purchase price. Following this award, his directly owned holdings total 217,832 common shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Reed Kendal

(Last) (First) (Middle)

C/O INNOVEX INTERNATIONAL, INC.

19120 KENSWICK DRIVE

(Street)

HUMBLE TX 77338

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Innovex International, Inc. [ INVX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/27/2026		A		18,975	A	$0	217,832	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Matt Steinheider, Attorney-in-Fact for Kendal Reed	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Innovex International (INVX) report for Reed Kendal?

Innovex International reported that CFO Reed Kendal received a stock award of common shares. On February 27, 2026, he was granted 18,975 shares of Innovex common stock at no purchase price as a non-derivative, direct ownership award.

How many Innovex (INVX) shares were granted to the CFO in this Form 4?

The CFO, Reed Kendal, was granted 18,975 shares of Innovex common stock. This award was reported as a non-derivative transaction with a grant or award acquisition code and carried a price per share of $0.0000, indicating no cash payment.

What is Reed Kendal’s Innovex (INVX) share ownership after this stock award?

After the reported grant, Reed Kendal directly owns 217,832 shares of Innovex common stock. The Form 4 lists this figure as the total number of common shares held following the non-derivative grant or award acquisition on February 27, 2026.

Was the Innovex (INVX) CFO’s Form 4 transaction a purchase or an award?

The transaction was an award, not an open-market purchase. The Form 4 classifies it under code A as a “grant, award, or other acquisition,” with a transaction price per share of $0.0000, confirming it was granted as compensation rather than bought.

Does the Innovex (INVX) Form 4 show direct or indirect ownership for this grant?

The Form 4 shows the 18,975-share grant as directly owned. The ownership type is labeled as non-derivative common stock with a direct ownership code “D,” and no nature-of-ownership footnote describes any trust, LLC, or other indirect holding entity.